SMTL ID : 5cxh.1

SYK catalytic domain complexed with a potent orally bioavailable thiazole inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x 55M: (4R)-4-[(1R)-1-{[6-(3,4-dimethoxyphenyl)[1,3]thiazolo[5,4-c]pyridin-4-yl]oxy}ethyl]pyrrolidin-2-one(Non-covalent)

55M.1: 21 residues within 4Å: Chain A: L.25, G.26, S.27, G.28, V.33, A.48, K.50, M.96, E.97, M.98, A.99, E.100, L.101, G.102, P.103, K.106, R.146, N.147, L.149, S.159, D.160 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.25 Hydrogen bonds: A:K.50, A:A.99, A:K.106, A:S.159, A:S.159, A:D.160 Water bridges: A:N.147

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Thoma, G. et al., Orally bioavailable Syk inhibitors with activity in a rat PK/PD model. Bioorg.Med.Chem.Lett. (2015)

Release Date

2015-09-23

Peptides

Tyrosine-protein kinase SYK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase SYK

Related Entries With Identical Sequence